Lv11
30 积分 2024-08-02 加入
Molecular chameleons in drug discovery
9小时前
待确认
Clinical Assessment of Drug Transporter Inhibition Using Biomarkers: Review of the Literature (2015–2024)
24天前
已完结
Utilization of OATP1B Biomarker Coproporphyrin‐I to Guide Drug–Drug Interaction Risk Assessment: Evaluation by the Pharmaceutical Industry
1个月前
已完结
Clinical Pharmacokinetics of Semaglutide: A Systematic Review
1个月前
已完结
Utilization of OATP1B Biomarker Coproporphyrin‐I to Guide Drug–Drug Interaction Risk Assessment: Evaluation by the Pharmaceutical Industry
2个月前
已完结
Exploring the molecular mechanisms of tirzepatide in alleviating metabolic dysfunction-associated fatty liver in mice through integration of metabolomics, lipidomics, and proteomics
2个月前
已完结
Novel LC-MS/MS analysis of the GLP-1 analog semaglutide with its application to pharmacokinetics and brain distribution studies in rats
3个月前
已完结
Novel LC-MS/MS analysis of the GLP-1 analog semaglutide with its application to pharmacokinetics and brain distribution studies in rats
3个月前
已完结
Simple Evaluation Method for CYP3A4 Induction from Human Hepatocytes: The Relative Factor Approach with an Induction Detection Limit Concentration Based on the Emax Model
4个月前
已完结
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance
5个月前
已完结
皖公网安备34019202002308
